Cart
sales@molnova.com
Bromo-PEG3-C2-acid
CAS No. 782475-35-8
Bromo-PEG3-C2-acid( —— )
Catalog No. M24782 CAS No. 782475-35-8
Bromo-PEG3-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 26 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBromo-PEG3-C2-acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionBromo-PEG3-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionBromo-PEG3-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number782475-35-8
-
Formula Weight285.13
-
Molecular FormulaC9H17BrO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CCOCCOCCOCCBr
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
5-Ethynyl-2-deoxyuri...
5-Ethynyl-2'-deoxyuridine (EdU) is a nucleoside analog of thymidine used to monitor de novo DNA synthesis through click chemistry and serves as an alkyl chain-based PROTAC linker for synthesizing PROTACs.
-
Amino-PEG4-Boc
Amino-PEG4-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
dBET1
dBET1 is a proteolysis-targeting chimera (PROTAC) molecule that appendes a competitive antagonist of BET bromodomain (JQ1) to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.
